loading page

Proteomic remodeling in the failing left ventricle adapting to dyssynchrony
  • +2
  • Karin Ljung,
  • Nitha Aima Muntu,
  • Ulrika Reistam,
  • Jonathan Kirk,
  • Marcus Ståhlberg
Karin Ljung
Karolinska Institute Department of Medicine Solna

Corresponding Author:[email protected]

Author Profile
Nitha Aima Muntu
Loyola University Chicago Stritch School of Medicine
Author Profile
Ulrika Reistam
Karolinska Institute Department of Medicine Solna
Author Profile
Jonathan Kirk
Loyola University Chicago Stritch School of Medicine
Author Profile
Marcus Ståhlberg
Karolinska Institute Department of Medicine Solna
Author Profile

Abstract

Purpose In heart failure, dyssynchrony is associated with accelerated cardiac remodeling and a worse prognosis. Both restored with resynchronization. We have previously developed a mouse model of dyssynchrony and resynchronization and here assess changes in protein expression within that model. Experimental design Mice were subjected to ischemia/reperfusion followed by pacemaker implantation. Three groups were defined: (i) sinus rhythm four weeks - synchronous heart failure (SynHF), (ii) right ventricular pacing (RVP) four weeks - dyssynchronous heart failure (DysHF) and (iii) RVP two weeks followed by two weeks sinus rhythm - resynchronized heart failure (ResynHF). Heart tissue was evaluated for protein content with mass spectrometry. Results A total of 3324 proteins were detected. The abundance of 589 proteins differed between DysHF and SynHF and 253 between DysHF and ResynHF. The changed proteins in the comparisons to DysHF overlapped to a great extent. Among the dysregulated proteins in DysHF were several immunoglobulin chains and extracellular matrix proteins. Conclusion Adding dyssynchrony to ischemic heart failure resulted in protein dysregulation, which was partly reversed with resynchronization. The dysregulation was characterized by an increased immune activity and skewing of the extracellular matrix proteins, which may be part of the remodeling process in DysHF.
07 Feb 2025Submitted to Clinical Applications
17 Feb 2025Submission Checks Completed
17 Feb 2025Assigned to Editor
17 Feb 2025Review(s) Completed, Editorial Evaluation Pending
17 Feb 2025Reviewer(s) Assigned